TOMO Insider Trading Activity and SEC Form 4 Filings
TOMO insider trading summary
No open-market insider purchases or sales of TomoTherapy Inc (TOMO) have been reported on SEC Form 4 in the past 12 months.
Latest TOMO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 20, 2010 | Lance C Balk | Director | Buy | $22K (6,900 @ $3.21) |
| Aug 20, 2010 | Lance C Balk | Director | Buy | $32K (10,000 @ $3.23) |
| May 12, 2010 | Cary J Nolan | Director | Sell | $56K (15,000 @ $3.70) |
| Apr 30, 2010 | A Eric Schloesser | VP, Operations & Bus. Dev't. | Sell | $975 (250 @ $3.90) |
| Apr 30, 2010 | A Eric Schloesser | VP, Operations & Bus. Dev't. | Sell | $839K (214,267 @ $3.92) |
| Apr 30, 2010 | A Eric Schloesser | VP, Operations & Bus. Dev't. | Sell | $590 (150 @ $3.93) |
| Apr 29, 2010 | Cary J Nolan | Director | Sell | $27K (6,988 @ $3.90) |
| Apr 28, 2010 | Cary J Nolan | Director | Sell | $31K (8,012 @ $3.90) |
| Mar 10, 2010 | Cary J Nolan | Director | Sell | $100K (31,000 @ $3.22) |
| Feb 25, 2010 | Cary J Nolan | Director | Sell | $43K (12,800 @ $3.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.